Publicaciones en las que colabora con JOSÉ PABLO MIRAMONTES GONZÁLEZ (24)

2023

  1. Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality

    Precision Cancer Medicine

  2. Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

    Cancers, Vol. 15, Núm. 17

  3. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID-19 pneumonia: An open-label randomised trial

    European Journal of Clinical Investigation, Vol. 53, Núm. 1

  4. Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis

    Chinese Clinical Oncology, Vol. 12, Núm. 6

  5. Reply to «Considerations to the manuscript cancer and elderly: Two incompatible concepts for intensive care?»

    Revista Espanola de Geriatria y Gerontologia

2022

  1. Cancer and elderly: Two incompatible concepts for intensive care?

    Revista Espanola de Geriatria y Gerontologia

  2. Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88

  3. Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

    Biomedicines, Vol. 10, Núm. 2

2021

  1. Dopamine receptors and the kidney: An overview of health-and pharmacological-targeted implications

    Biomolecules, Vol. 11, Núm. 2, pp. 1-16

  2. Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors

    Life, Vol. 11, Núm. 12

  3. Resistance to immune checkpoint inhibitors secondary to myeloid-derived suppressor cells: A new therapeutic targeting of haematological malignancies

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  4. The influence of diet and probiotics on the response of solid tumours to immunotherapy: Present and future perspectives

    Applied Sciences (Switzerland), Vol. 11, Núm. 18

2020

  1. Author Correction: A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function (Scientific Reports, (2019), 9, 1, (5055), 10.1038/s41598-019-41504-7)

    Scientific Reports

  2. VAV3 rs7528153 and VAV3-AS1 rs1185222 polymorphisms are associated with an increased risk of developing hypertension

    European Journal of Internal Medicine, Vol. 80, pp. 60-65

2019

  1. A new common functional coding variant at the DDC gene change renal enzyme activity and modify renal dopamine function

    Scientific Reports, Vol. 9, Núm. 1

2012

  1. Four-month history of weakness of lower limbs in a 50-years-old male

    Medicina Clinica, Vol. 138, Núm. 5, pp. 230

2011

  1. Destrucción del carpo secundaria a gota sin tratamiento

    Medicina general, Núm. 137, pp. 148

  2. Dyspnea of one-month duration in a 62 years-old woman

    Medicina Clinica, Vol. 137, Núm. 12, pp. 574

  3. Variabilidad genética de endotelina, enos, ppargamma, vav-2 y vav-3 asociada a riesgo vascular

    Variabilidad genética de endotelina, enos, ppargamma, vav-2 y vav-3 asociada a riesgo vascular

2010

  1. Endocarditis secundaria a cateter de derivación ventriculo-atrial

    Anales del sistema sanitario de Navarra, Vol. 33, Núm. 1, pp. 93-95